Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results ...
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results ...
Source: pr-inside.com
Page 3 - Mark Oki News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Oki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Oki Today - Breaking & Trending Today
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing ...
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing ...
Source: pr-inside.com
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference ...
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference ...
Source: pr-inside.com
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2023 Earnings Call Transcript
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2023 Earnings Call Transcript September 27, 2023 Operator: Greetings. Welcome to the Aytu BioPharma Fiscal 2023 Q4 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now […]
Source: yahoo.com
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
27.09.2023 - Q4 2023 net revenue of $30.7 million; Adjusted EBITDA of $7.7 millionRecord Q4 2023 total prescriptions increased 32% compared to Q4 2022Rx Segment net revenue of $23.3 million and Adjusted EBITDA of $8.3 million in Q4 2023Company to host conference ...
Source: wallstreet-online.de